DK0510837T3 - Synergistiske kombinationer til behandling af angsttilstande - Google Patents

Synergistiske kombinationer til behandling af angsttilstande

Info

Publication number
DK0510837T3
DK0510837T3 DK92303155.3T DK92303155T DK0510837T3 DK 0510837 T3 DK0510837 T3 DK 0510837T3 DK 92303155 T DK92303155 T DK 92303155T DK 0510837 T3 DK0510837 T3 DK 0510837T3
Authority
DK
Denmark
Prior art keywords
anxiety disorders
synergistic combinations
treat anxiety
pyrimidyl
pyrazine
Prior art date
Application number
DK92303155.3T
Other languages
Danish (da)
English (en)
Inventor
Patricia Ann Seymour
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0510837T3 publication Critical patent/DK0510837T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DK92303155.3T 1991-04-23 1992-04-09 Synergistiske kombinationer til behandling af angsttilstande DK0510837T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/690,412 US5124346A (en) 1991-04-23 1991-04-23 Synergistic combinations in the treatment of anxiety

Publications (1)

Publication Number Publication Date
DK0510837T3 true DK0510837T3 (da) 1997-09-29

Family

ID=24772351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92303155.3T DK0510837T3 (da) 1991-04-23 1992-04-09 Synergistiske kombinationer til behandling af angsttilstande

Country Status (17)

Country Link
US (1) US5124346A (ko)
EP (1) EP0510837B1 (ko)
JP (1) JP2554819B2 (ko)
KR (1) KR960002181B1 (ko)
AT (1) ATE157540T1 (ko)
AU (1) AU634118B1 (ko)
CA (1) CA2066525C (ko)
DE (1) DE69221926T2 (ko)
DK (1) DK0510837T3 (ko)
HU (1) HU216632B (ko)
IE (1) IE921257A1 (ko)
IL (1) IL101626A (ko)
MX (1) MX9201858A (ko)
MY (1) MY109140A (ko)
NZ (1) NZ242429A (ko)
TW (1) TW252916B (ko)
ZA (1) ZA922898B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688518A (en) * 1992-02-27 1997-11-18 Alza Corporation Antidepressive therapy
US5858407A (en) * 1992-02-27 1999-01-12 Alza Corporation Method for administering tandospirone
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
FR2746314B1 (fr) * 1996-03-25 1998-06-12 Pf Medicament Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee

Also Published As

Publication number Publication date
KR960002181B1 (ko) 1996-02-13
CA2066525C (en) 1995-05-30
IL101626A0 (en) 1992-12-30
US5124346A (en) 1992-06-23
HUT62796A (en) 1993-06-28
EP0510837A3 (en) 1993-07-28
MY109140A (en) 1996-12-31
HU216632B (hu) 1999-07-28
ZA922898B (en) 1993-10-22
NZ242429A (en) 1993-08-26
IE921257A1 (en) 1992-11-04
EP0510837A2 (en) 1992-10-28
MX9201858A (es) 1992-10-01
ATE157540T1 (de) 1997-09-15
DE69221926T2 (de) 1998-01-02
DE69221926D1 (de) 1997-10-09
EP0510837B1 (en) 1997-09-03
IL101626A (en) 1996-07-23
HU9201307D0 (en) 1992-07-28
AU634118B1 (en) 1993-02-11
KR920019355A (ko) 1992-11-19
JPH05213742A (ja) 1993-08-24
TW252916B (ko) 1995-08-01
JP2554819B2 (ja) 1996-11-20

Similar Documents

Publication Publication Date Title
ATE244719T1 (de) N-7 heterocyclyl-pyrrolo( 2,3-d)pyrimidine und ihre verwendung
NO952398D0 (no) Pyrrolpyrimidiner som CRF antagonister
AP9901435A0 (en) Bicycle heteroaromatic compounds as protein tyrosine kinase inhibitors.
ATE136542T1 (de) Pyrimidine und deren pharmazeutisch brauchbare salze und deren verwendung als arzneimittel
MY134848A (en) Pyrrolo[2,1-f] [1,2,4] triazine inhibitors of kinases
DE60041710D1 (de) Polycycloalkylpurine als adenosinrezeptorantagonisten
LV12292A (lv) Triazinu un pirimidinu azoloatvasinajumi
RS52389B (en) HETEROCYCLIC UNITS BASED ON N6-SUBSTITUTED ADENINE, MANUFACTURING PROCEDURES, THEIR USE FOR THE PRODUCTION OF MEDICINES, COSMETICS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC REGULATORS
MX9205046A (es) 1h-imidazo-(4,5-c)quinolin-4-aminas 1-substituidas
YU48528B (sh) Analozi 5-(1-hidroksi-2-piperidinopropil)-2-(1h,3h)-indolona
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
MXPA03010269A (es) Derivados de 2,5-disubstituida piridina, pirimidina, piridazina y 1,2,4-triazina para usarse como inhibidores de p38.
DK0510837T3 (da) Synergistiske kombinationer til behandling af angsttilstande
DK0580753T3 (da) Pyrimidinderivater til forøgelse af antitumoraktivitet
ES2114900T3 (es) Preparacion para promover el crecimiento del cabello.
DK0579968T3 (da) 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse
ES2018025B3 (es) Nuevas amidas sustituidas, su preparacion y las composiciones farmaceuticas que las contienen.
MXPA02012260A (es) 2-aminoalquil-tieno[2,3-d]pirimidinas.
AU6886887A (en) Sulphonamide /diaminopyrimidine compositions for the treatment of microbial infections
DK44385D0 (da) 6-substituerede 5-phenyltetrazolo(1,5-a)(1,2,4)triazolo(1,5-c)pyrimidiner
ES2168269T3 (es) Intermedios y procedimientos para los mismos, para la preparacion de 5,6-dihidropirrolo(2,3-d)pirimidina.
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
FI954340A0 (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2,4-triazolo(1,5-a)-pyrimidinderivat